LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

Search

Dynavax Technologies Corp

Closed

SectorHealthcare

9.4 -2.69

Overview

Share price change

24h

Current

Min

9.36

Max

9.53

Key metrics

By Trading Economics

Income

-11M

7.1M

Sales

-8.6M

72M

P/E

Sector Avg

58.75

54.379

EPS

0.05

Profit margin

9.787

Employees

405

EBITDA

1.3M

11M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+157.7% upside

Dividends

By Dow Jones

Next Earnings

5 Aug 2025

Market Stats

By TradingEconomics

Market Cap

-277M

1.4B

Previous open

12.09

Previous close

9.4

News Sentiment

By Acuity

43%

57%

147 / 382 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Dynavax Technologies Corp Chart

Past performance is not a reliable indicator of future results.

Related News

11 May 2025, 23:48 UTC

Earnings
Acquisitions, Mergers, Takeovers

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11 May 2025, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11 May 2025, 23:45 UTC

Market Talk

Oil Rises Amid Improved Market Mood -- Market Talk

11 May 2025, 23:38 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Aristocrat Has Significant Firepower for M&A -- Market Talk

11 May 2025, 23:36 UTC

Market Talk

Global Markets Uncertain About US-China Trade News -- Market Talk

11 May 2025, 23:35 UTC

Market Talk

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11 May 2025, 23:33 UTC

Earnings
Acquisitions, Mergers, Takeovers

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11 May 2025, 23:32 UTC

Top News

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11 May 2025, 22:44 UTC

Market Talk

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11 May 2025, 22:33 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11 May 2025, 20:19 UTC

Top News

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11 May 2025, 16:00 UTC

Top News

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11 May 2025, 11:00 UTC

Top News

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11 May 2025, 08:00 UTC

Top News

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11 May 2025, 01:00 UTC

Top News

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11 May 2025, 01:00 UTC

Top News

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10 May 2025, 21:54 UTC

Top News

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10 May 2025, 17:12 UTC

Top News

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10 May 2025, 15:41 UTC

Top News

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10 May 2025, 12:00 UTC

Top News

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10 May 2025, 09:30 UTC

Top News

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10 May 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

10 May 2025, 03:52 UTC

Top News

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9 May 2025, 23:51 UTC

Acquisitions, Mergers, Takeovers

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9 May 2025, 22:06 UTC

Market Talk

Arm Holdings Remains a Strong Growth Story -- Market Talk

9 May 2025, 21:37 UTC

Top News

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9 May 2025, 21:10 UTC

Top News

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9 May 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9 May 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

9 May 2025, 20:42 UTC

Top News

Stocks Get a Break From Trade Chaos -- WSJ

Peer Comparison

Price change

Dynavax Technologies Corp Forecast

Price Target

By TipRanks

157.7% upside

12 Months Forecast

Average 24.25 USD  157.7%

High 31 USD

Low 10 USD

Based on 5 Wall Street analysts offering 12 month price targets forDynavax Technologies Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

4

Buy

0

Hold

1

Sell

Technical Score

By Trading Central

9.62 / 10.9Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Very Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

147 / 382 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.